OMED
OncoMed Pharmaceuticals, Inc.
OMED
OMED
Delisted
OMED was delisted on the 22nd of April, 2019.
84 hedge funds and large institutions have $141M invested in OncoMed Pharmaceuticals, Inc. in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
13% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 8
1% more funds holding
Funds holding: 83 → 84 (+1)
Holders
84
Holding in Top 10
2
Calls
$790K
Puts
$608K
Top Buyers
| 1 | +$4.71M | |
| 2 | +$2.03M | |
| 3 | +$1.4M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$1.31M |
| 5 |
TI
Turner Investments
Berwyn,
Pennsylvania
|
+$1.16M |
Top Sellers
| 1 | -$1.32M | |
| 2 | -$1.13M | |
| 3 | -$905K | |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$832K |
| 5 |
JPMorgan Chase & Co
New York
|
-$466K |